A Rare Case of Pembrolizumab-Induced Uveitis in a Patient with Metastatic Melanoma
Author:
Affiliation:
1. Hematology/Oncology Clinical Pharmacist; Mayo Clinic; Rochester Minnesota
Publisher
Wiley
Subject
Pharmacology (medical)
Reference27 articles.
1. Degree, duration, and causes of visual loss in uveitis;Durrani;Br J Ophthalmol,2004
2. Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies;Naidoo;Ann Oncol,2015
3. Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper;Champiat;Ann Oncol,2016
4. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma;Hamid;N Engl J Med,2013
5. Efficacy and safety of the anti-PD-1 monoclonal antibody pembrolizumab (MK-3475) in 411 patients (pts) with melanoma (MEL);Ribas;J Clin Oncol,2014
Cited by 49 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Diagnosing and Managing Uveitis Associated with Immune Checkpoint Inhibitors: A Review;Diagnostics;2024-02-04
2. Immune checkpoint inhibitor-related hearing loss: a systematic review and analysis of individual patient data;Supportive Care in Cancer;2023-10-11
3. Ocular adverse events associated with immune checkpoint inhibitors, a scoping review;Journal of Ophthalmic Inflammation and Infection;2023-02-22
4. Case Report: Serial changes of ocular complications related to immune checkpoint inhibitors pembrolizumab and nivolumab;Frontiers in Ophthalmology;2023-01-05
5. Clinical Manifestations, Diagnosis, Treatment and Prognosis of Uveitis Induced by Anticancer Drugs: A Review of Literature;Brain Sciences;2022-08-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3